Not Tagged
Not Tagged
[' vedo', 'tofacitinib', 'ibd', 'upadacitinib', 'infliximab', ' uc ', 'ustekinumab', 'adalimumab', 'ozanimod', 'vedolizumab', 'tofa', 'imab ']
very important information from at #cccongress23: therapeutic efficacy of jak inhibitors vs other #ibd therapies. important to consider jaki in acute severe uc (asuc). there is a window of opportunity and safety profiles are similar or better than existing #biologics. 
Multi Award-Winning #IBD & #FGID Patient Advocate • Team @southasianibd & @ibdesis • MPH ‘23 @IcahnMountSinai • She/Her